April 22 (Reuters) - CellaVision AB CEVI.ST :
* REG-CELLAVISION AB: STABLE START OF THE YEAR WITH GOOD
GROWTH IN
APAC
* Q1 NET SALES SEK 134.4 MILLION VERSUS SEK 103.9 MILLION
YEAR AGO
* Q1 EBITDA SEK 41.2 MILLION VERSUS SEK 38.3 MILLION YEAR
AGO
* EXPECTS COVID-19-PANDEMIC TO HAVE A SIGNIFICANT NEGATIVE
IMPACT
ON CELLAVISION'S SALES AND EARNINGS FOR A NUMBER OF MONTHS
Source text for Eikon: ID:nGNE4ZJHb1
Further company coverage: CEVI.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))